Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 16CNS 8Sarcoma 2Head & Neck 2Gastrointestinal 2Dermatologic 2Thoracic 1Lymphoid 1Breast 1

Conditions

Sarcoma 2Pathologic Complete Response 1Neoplasms 1

Interventions

Radiotherapy 216Cyclophosphamide 211Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 79Irinotecan 79pembrolizumab 75Radiation 67Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 45Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Transurethral Resection of Bladder × Sarcoma × Clear all
NCT05684874 2023-10-30

SarQuantIRM

Centre Leon Berard

Phase NA Unknown
25 enrolled
Sarcoma

Pathologic Complete Response, Neoplasms, Sarcoma

NCT02579980 2019-03-26

Quantitative Imaging Biomarkers for Sarcoma

Columbia University

Phase NA Completed
32 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡